News

Nencki Institute to test a self-administered tool for early detection of retinal disease

Modern medicine still cannot treat many forms of retinal damage, and patients often see an ophthalmologist only when visual impairment is already advanced. A team led by Dr. Kalina Burnat at the Nencki Institute will test a self-administered tool for the early detection of visual impairment and investigate how progressive disease affects the entire visual system. The findings may help lay the groundwork for precise vision neurorehabilitation for patients and people at risk of developing ...